Disciplined Practice and Improving Clinical and Pathologic Staging for Non-Small Cell Lung Cancer

被引:1
|
作者
Putnam, Joe B., Jr. [1 ,2 ]
机构
[1] Vanderbilt Univ, Dept Thorac Surg, Nashville, TN 37235 USA
[2] Vanderbilt Univ, Dept Biomed Informat, Nashville, TN 37235 USA
来源
ANNALS OF THORACIC SURGERY | 2014年 / 97卷 / 03期
关键词
LYMPH-NODE EVALUATION; ED AMERICAN-COLLEGE; GROUP Z0030 TRIAL; PRACTICE GUIDELINES; THORACOSCOPIC LOBECTOMY; LYMPHADENECTOMY; THORACOTOMY; MANAGEMENT; DIAGNOSIS; RESECTIONS;
D O I
10.1016/j.athoracsur.2013.12.040
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:744 / 746
页数:3
相关论文
共 50 条
  • [41] Pathologic Assessment and Staging of Multiple Non-Small Cell Lung Carcinomas: A Paradigm Shift with the Emerging Role of Molecular Methods
    Chang, Jason C.
    Rekhtman, Natasha
    MODERN PATHOLOGY, 2024, 37 (05)
  • [42] Spectral CT and its specific values in the staging of patients with non-small cell lung cancer: technical possibilities and clinical impact
    Fehrenbach, U.
    Kahn, J.
    Boening, G.
    Feldhaus, F.
    Merz, K.
    Frost, N.
    Maurer, M. H.
    Renz, D.
    Hamm, B.
    Streitparth, F.
    CLINICAL RADIOLOGY, 2019, 74 (06) : 456 - 466
  • [43] Differences in Practice Patterns and Costs between Small Cell and Non-Small Cell Lung Cancer Patients in Japan
    Kuwabara, Kazuaki
    Matsuda, Shinya
    Fushimi, Kiyohide
    Anan, Makoto
    Ishikawa, Koichi B.
    Horiguchi, Hiromasa
    Hayashida, Kenshi
    Fujimori, Kenji
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 217 (01): : 29 - 35
  • [44] Segmentectomy for clinical stage I non-small cell lung cancer: National benchmarks for nodal staging and outcomes by operative approach
    Kneuertz, Peter J.
    Abdel-Rasoul, Mahmoud
    D'Souza, Desmond M.
    Zhao, Jing
    Merritt, Robert E.
    CANCER, 2022, 128 (07) : 1483 - 1492
  • [45] Non-small cell lung cancer: epidemiology, screening, diagnosis, and treatment
    Shukla, Anuj A.
    Podder, Shreya
    Chaudry, Sana R.
    Benn, Bryan S.
    Kurman, Jonathan S.
    AIMS MEDICAL SCIENCE, 2022, 9 (02): : 348 - 361
  • [46] Validation of a blood protein signature for non-small cell lung cancer
    Mehan, Michael R.
    Williams, Stephen A.
    Siegfried, Jill M.
    Bigbee, William L.
    Weissfeld, Joel L.
    Wilson, David O.
    Pass, Harvey I.
    Rom, William N.
    Muley, Thomas
    Meister, Michael
    Franklin, Wilbur
    Miller, York E.
    Brody, Edward N.
    Ostroff, Rachel M.
    CLINICAL PROTEOMICS, 2014, 11
  • [47] Treatment Delays in Non-small Cell Lung Cancer and Their Prognostic Implications
    Diaconescu, Razvan
    Lafond, Chantal
    Whittom, Renaud
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (07) : 1254 - 1259
  • [48] Updates on Minimally Invasive Surgery in Non-Small Cell Lung Cancer
    Ikeda, Norihiko
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (02)
  • [49] Relevance of matrix metalloproteases in non-small cell lung cancer diagnosis
    Blanco-Prieto, Sonia
    Barcia-Castro, Leticia
    Paez de la Cadena, Maria
    Javier Rodriguez-Berrocal, Francisco
    Vazquez-Iglesias, Lorena
    Isabel Botana-Rial, Maria
    Fernandez-Villar, Alberto
    De Chiara, Loretta
    BMC CANCER, 2017, 17
  • [50] Videothoracoscopic approach to stage I non-small cell lung cancer
    Vergani, Contardo
    Varoli, Federico
    Despini, Luca
    Fratus, Giorgio
    Venturi, Marco
    Roviaro, Giancarlo
    ANNALI ITALIANI DI CHIRURGIA, 2014, 85 (06) : 525 - 532